tiprankstipranks
Trending News
More News >
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Cash flow

Compare
238 Followers

NewAmsterdam Pharma Company Cash Flow

NAMS's free cash flow for Q3 2025 was $-32.81M. For the 2025 fiscal year, NAMS's free cash flow was decreased by $-17.99M and operating cash flow was $-32.77M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -158.56M$ -141.22M$ 10.66M$ -29.51M-
Investing Cash Flow
$ -62.85M$ -24.00K$ -221.00K$ -24.00K-
Financing Cash Flow
$ 659.51M$ 8.91M$ 391.90M$ 84.70M$ 13.92M
End Cash Position
$ 771.74M$ 340.45M$ 467.73M$ 60.13M$ 9.67M
Free Cash Flow
$ -159.24M$ -141.24M$ 10.44M$ -29.54M-
Currency in USD

NewAmsterdam Pharma Company Cash Flow